← Back to All Filings

HealthEquity EVP Sells $157k in Stock via 10b5-1 Plan

Low SignificanceNovember 24, 2025 at 5:33:30 PM EST

HEALTHEQUITY, INC.

$HQY4CIK: 0001428336

Subscribe to track HQY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

HealthEquity EVP Sells $157k in Stock via 10b5-1 Plan

Company: HEALTHEQUITY, INC. (HQY) Form: 4 | Filed: 2025-11-24 Significance: Low

Insider: Ladd Delano Title: EVP, General Counsel | Relationship: Officer

Transaction: • Type: Sell • Shares: 1,500 • Price: $104.56 • Value: $156,840 • Owned After: 75,479

Key Insight: A small, pre-planned sale by an executive, representing a minor fraction of their holdings (<2%) and a negligible portion of the company's market cap (0.0018%).

Market Context: The sale was executed under a Rule 10b5-1 trading plan adopted in June 2025, indicating it was scheduled in advance and not based on immediate market events.

Comprehensive Analysis

SEC Filing Analysis: HEALTHEQUITY, INC. (HQY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An executive conducted a small, pre-planned sale of common stock with negligible market impact.
  • Market Impact: Neutral. The transaction's small size and pre-scheduled nature under a 10b5-1 plan suggest it is a routine financial management activity.

Company Information

FieldValue
CompanyHEALTHEQUITY, INC.
Ticker SymbolHQY
CIK0001428336
IndustryServices-Business Services, NEC

Insider Information

FieldValue
NameLadd Delano
CIK0001683056
Title/PositionEVP, General Counsel
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-20
Transaction CodeS (Open market or private sale of securities)
Security TypeCommon Stock
Shares Involved1,500
Price Per Share$104.56
Total Value$156,840
Shares Owned After75,479
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$156,840
% of Market Cap0.0018%
Shares Transacted1,500
% of Shares Outstanding0.0017%
Post-Transaction Ownership75,479 shares (0.088% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $8.77 billion, this $156,840 transaction is financially immaterial to the company.
  • Ownership Concentration: The sale represents a very small portion (approx. 1.95%) of the insider's total direct holdings, and their remaining stake is minor relative to the total shares outstanding.
  • Transaction Significance: The transaction falls well below the thresholds for moderate significance. Its value is less than 0.1% of market cap and the shares involved are less than 0.1% of shares outstanding.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to influence market perception. The fact that it was executed under a 10b5-1 plan further reduces its informational value, as it was not a spontaneous decision based on current events.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume for a multi-billion dollar company.
  • Sentiment Indicator: Neutral. This filing is unlikely to affect investor sentiment.

Additional Context

Special Circumstances

  • The filing notes that the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025. This indicates a pre-scheduled transaction for portfolio management or diversification purposes, rather than a reaction to recent company performance.
Topics:#SECFiling#InsiderTrading#HQY#HealthEquity#Form4#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.